CAPTRUST Financial Advisors’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Buy |
51,492
+4,297
| +9% | +$16.5K | ﹤0.01% | 2312 |
|
|
2025
Q1 | $271K | Buy |
47,195
+26,500
| +128% | +$152K | ﹤0.01% | 1995 |
|
|
2024
Q4 | $103K | Buy |
20,695
+1,434
| +7% | +$7.16K | ﹤0.01% | 2202 |
|
|
2024
Q3 | $104K | Buy |
19,261
+9,087
| +89% | +$49K | ﹤0.01% | 2199 |
|
|
2024
Q2 | $33.7K | Buy |
10,174
+135
| +1% | +$447 | ﹤0.01% | 2164 |
|
|
2024
Q1 | $32.8K | Sell |
10,039
-9,453
| -48% | -$30.9K | ﹤0.01% | 2102 |
|
|
2023
Q4 | $68.4K | Sell |
19,492
-10,936
| -36% | -$38.4K | ﹤0.01% | 2561 |
|
|
2023
Q3 | $203K | Buy |
30,428
+15,339
| +102% | +$102K | ﹤0.01% | 2279 |
|
|
2023
Q2 | $127K | Buy |
+15,089
| New | +$127K | ﹤0.01% | 2348 |
|
|
2022
Q3 | – | Sell |
-1,089
| Closed | -$4K | – | 2119 |
|
|
2022
Q2 | $4K | Sell |
1,089
-181
| -14% | -$665 | ﹤0.01% | 4157 |
|
|
2022
Q1 | $6K | Buy |
1,270
+770
| +154% | +$3.64K | ﹤0.01% | 4045 |
|
|
2021
Q4 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 4385 |
|